apixaban malignancy

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
apixaban malignancy	1.09	1	5590	44	19
apixaban	0.48	1	6964	11	8
malignancy	0.28	0.8	6464	64	10

Keyword	CPC	PCC	Volume	Score
apixaban malignancy	1.27	0.4	4152	5
apixaban vs enoxaparin in malignancy	1.27	0.6	962	70
apixaban for pe in malignancy	0.98	0.2	403	74
difference between enoxaparin and apixaban	1.77	0.8	231	4
enoxaparin and apixaban together	1.39	0.4	2607	2
apixaban to enoxaparin conversion	0.97	0.8	3073	98
transitioning from apixaban to enoxaparin	1.59	0.8	2625	92
switch from enoxaparin to apixaban	1.41	0.8	5603	61
transition from enoxaparin to apixaban	0.9	0.2	6348	32
switching from enoxaparin to apixaban	1.96	0.2	219	65
bridging apixaban with enoxaparin	1.97	1	4405	50
apixaban loading dose after enoxaparin	1.22	0.6	5388	74
enoxaparin in cancer patients	0.01	1	6173	8
apixaban in oncology patients	1.71	0.2	83	33
apixaban in cancer patients	0.69	0.6	5037	61
edoxaban vs rivaroxaban and apixaban	2	0.5	2418	89
apixaban vs edoxaban bleeding risk	0.82	0.9	4277	48
edoxaban compared to apixaban	1.42	0.7	6006	13
enoxaparin anti xa monitoring	0.63	0.9	6742	67
enoxaparin expected pharmacological action	0.27	1	7748	100
enoxaparin classification and action	0.83	0.6	8591	50
enoxaparin evaluation of effectiveness	1.15	0.2	8170	41